secwatch / observer
8-K filed February 23, 2026, 6:59 PM ET ticker ALUR CIK 0001964979
regulatory confidence high sentiment positive materiality 0.85

FDA grants PMA approval for Allurion gastric balloon system for obesity

ALLURION TECHNOLOGIES, INC.

item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-062599
form_type
8-K
ticker
ALUR
cik
0001964979
company_name
ALLURION TECHNOLOGIES, INC.
filed_at
2026-02-23T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.893694+00:00
generated_at
2026-05-16T01:16:25.907588+00:00
sec_items
["7.01", "9.01"]
event_type
regulatory
sentiment
positive
materiality_score
0.85
calibrated_materiality_score
0.85
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-062599
json_url
https://secwatch.observer/filing/0001193125-26-062599.json
markdown_url
https://secwatch.observer/filing/0001193125-26-062599.md
text_url
https://secwatch.observer/filing/0001193125-26-062599.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/0001193125-26-062599-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/alur-20260223.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

REPL

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc. May 29, 2026, 9:56 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

VSTD

Vestand receives Nasdaq delisting notice for late quarterly and annual filings

Vestand Inc. May 26, 2026, 5:18 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MDAI

Spectral AI receives FDA De Novo clearance for DeepView System for burn indication

Spectral AI, Inc. May 26, 2026, 4:00 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

NVVE

Nuvve receives Nasdaq delisting notice for late Q1 10-Q filing; already under $1.00 bid price review

Nuvve Holding Corp. May 22, 2026, 6:35 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

RGTI

Rigetti signs LOI for up to $100M CHIPS Act award for quantum R&D; government to receive equity

Rigetti Computing, Inc. May 21, 2026, 7:30 AM ET regulatory Items 3.02, 8.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

GYRE

Gyre Therapeutics' NDA for F351 accepted by China's NMPA for CHB-induced liver fibrosis

GYRE THERAPEUTICS, INC. May 12, 2026, 5:03 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MLTX

MoonLake aligns with FDA on BLA for sonelokimab in HS; Q1 cash $357.9M

MoonLake Immunotherapeutics May 11, 2026, 7:59 PM ET regulatory Items 2.02, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-062599
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.